Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Buy
368
+27
+8% +$596 0.01% 1619
2026
Q1
$5K Sell
341
-207
-38% -$3.04K ﹤0.01% 1821
2025
Q4
$7K Hold
548
﹤0.01% 1793
2025
Q3
$8K Sell
548
-1
-0.2% -$16 ﹤0.01% 1760
2025
Q2
$8K Buy
549
+3
+0.5% +$45 ﹤0.01% 1683
2025
Q1
$11K Buy
546
+2
+0.4% +$44 0.01% 1452
2024
Q4
$13K Buy
544
+15
+3% +$419 0.01% 1401
2024
Q3
$15K Hold
529
0.01% 1332
2024
Q2
$14K Buy
529
+2
+0.4% +$42 0.01% 1351
2024
Q1
$11K Sell
527
-2
-0.4% -$43 0.01% 1534
2023
Q4
$13K Buy
529
+11
+2% +$221 0.01% 1394
2023
Q3
$10K Sell
518
-112
-18% -$2.21K 0.01% 1441
2023
Q2
$14K Buy
630
+162
+35% +$3.26K 0.01% 1294
2023
Q1
$9K Sell
468
-179
-28% -$3.44K 0.01% 1382
2022
Q4
$11K Buy
+647
New +$11.5K 0.01% 1293

Other funds holding RXO

Covestor's RXO Position: Q2 2026 in Review

Covestor increased its RXO (RXO) stake by 7.9% in Q2 2026, buying an estimated $596 and bringing the position to 368 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1619.

Covestor first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $15K in Q3 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Covestor held 368 shares of RXO worth $10K as of Q2 2026.
  • Covestor bought 27 RXO shares in Q2 2026, an estimated $596.
  • RXO made up 0.01% of Covestor's portfolio in Q2 2026, its #1619 holding.
  • Covestor first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Covestor's RXO position peaked at $15K in Q3 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.